Abstract
Murine models of acute and chronic lung infection have been used in studying Pseudomonas aeruginosa for assessing in vivo behavior and for monitoring of the host response. These models provide an important resource for studies of the initiation and maintenance of bacterial infection, identify bacterial genes essential for in vivo maintenance and for the development and testing of new therapies. The rat has been used extensively as a model of chronic lung infection, whereas the mouse has been a model of acute and chronic infection. Intratracheal administration of planktonic bacterial cells in the mouse provides a model of acute pneumonia. Bacteria enmeshed in agar beads can be used in the rat and mouse to reproduce the lung pathology of cystic fibrosis patients with advanced chronic pulmonary disease. Here, we describe the methods to assess virulence of P. aeruginosa using prototype and clinical strains in the Sprague-Dawley rat and the C57BL/6NCrlBR mouse by monitoring several measurable read-outs including weight loss, mortality, in vivo growth curves, the competitive index of infectivity, and the inflammatory response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bianconi I et al (2011) Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection. PLoS Pathog 7:e1001270
Dunn MM, Toews GB, Hart D, Pierce AK (1985) The effects of systemic immunization of pulmonary clearance of Pseudomonas aeruginosa. Am Rev Respir Dis 131:426–431
Lore NI et al (2012) Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. PLoS ONE 7:e35648
Schook LB, Carrick L Jr, Berk RS (1977) Experimental pulmonary infection of mice by tracheal intubation of Pseudomonas aeruginosa: the use of antineoplastic agents to overcome natural resistance. Can J Microbiol 23: 823–826
Yu H, Hanes M, Chrisp CE, Boucher JC, Deretic V (1998) Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect Immun 66:280–288
McCray PB Jr, Zabner J, Jia HP, Welsh MJ, Thorne PS (1999) Efficient killing of inhaled bacteria in DeltaF508 mice: role of airway surface liquid composition. Am J Physiol 277: L183–L190
Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA (1979) A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 119:453–459
Klinger JD, Cash HA, Wood RE, Miler JJ (1983) Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats. Infect Immun 39:1377–1384
Bragonzi A et al (2006) Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 152:3261–3269
Hoiby N et al (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3:23–35
Hodgson AE, Nelson SM, Brown MR, Gilbert PA (1995) Simple in vitro model for growth control of bacterial biofilms. J Appl Bacteriol 79:87–93
Rejman J et al (2010) Impact of chronic pulmonary infection with Pseudomonas aeruginosa on transfection mediated by viral and nonviral vectors. Hum Gene Ther 21:351–356
Cantin AM, Woods DE (1999) Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 160:1130–1135
Amano H et al (2000) Role of cytokine-induced neutrophil chemoattractant-2 (CINC-2) alpha in a rat model of chronic bronchopulmonary infections with Pseudomonas aeruginosa. Cytokine 12:1662–1668
Omri A, Suntres ZE, Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64: 1407–1413
Potvin E et al (2003) In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5:1294–1308
Duan K, Dammel C, Stein J, Rabin H, Surette MG (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50:1477–1491
Lehoux DE, Sanschagrin F, Kukavica-Ibrulj I, Potvin E, Levesque RC (2004) Identification of novel pathogenicity genes by PCR signature-tagged mutagenesis and related technologies. Methods Mol Biol 266:289–304
Joly B et al (2005) Relative expression of Pseudomonas aeruginosa virulence genes analyzed by a real time RT-PCR method during lung infection in rats. FEMS Microbiol Lett 243: 271–278
Woods DE, Cantin A, Cooley J, Kenney DM, Remold-O’Donnell E (2005) Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 39:141–149
Zhang L et al (2005) Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 49:2921–2927
Boyer S et al (2005) Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance. Respir Res 6:17
Kukavica-Ibrulj I, Levesque RC (2008) Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab Anim 42:389–412
Lehoux DE, Sanschagrin F, Levesque RC (2000) Genomics of the 35-kb pvd locus and analysis of novel pvdIJK genes implicated in pyoverdine biosynthesis in Pseudomonas aeruginosa. FEMS Microbiol Lett 190: 141–146
Hava DL, Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45: 1389–1406
Kukavica-Ibrulj I et al (2008) In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J Bacteriol 190:2804–2813
Winstanley C et al (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res 19:12–23
Bragonzi A (2010) Murine models of acute and chronic lung infection with cystic fibrosis pathogens. Int J Med Microbiol 300: 584–593
Acknowledgements
R. C. Levesque is a research scholar of exceptional merit from the Fond de Recherche du Québec en Santé (FRQS). His laboratory is funded by the Canadian Institute for Health Research (CIHR), a CIHR-UK team grant, the CIHR-FRQS-Québec Respiratory Health Network (RSR), the Natural Sciences and Engineering Research Council of Canada (NSERC), Genome Québec, the Fonds de recherche du Québec Nature et technologies, and the Alberta Innovates Bio Solutions program.
Research in Bragonzi’s laboratory is funded by the Italian Cystic Fibrosis Foundation (CFaCore) and the European Commission (Grant NABATIVI, EU-FP7-HEALTH-2007-B, contract number 223670).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kukavica-Ibrulj, I., Facchini, M., Cigana, C., Levesque, R.C., Bragonzi, A. (2014). Assessing Pseudomonas aeruginosa Virulence and the Host Response Using Murine Models of Acute and Chronic Lung Infection. In: Filloux, A., Ramos, JL. (eds) Pseudomonas Methods and Protocols. Methods in Molecular Biology, vol 1149. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-0473-0_58
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0473-0_58
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-0472-3
Online ISBN: 978-1-4939-0473-0
eBook Packages: Springer Protocols